Skip to main content
. Author manuscript; available in PMC: 2013 Sep 28.
Published in final edited form as: J Pharmacol Exp Ther. 2008 Jul 29;327(2):442–452. doi: 10.1124/jpet.108.141291

TABLE 1.

IC50 values for cell lines treated with cisplatin ± BG

Cell Line IC50 (Cisplatin)
Fold Enhancement p Value
−BG +BG
μ M
Endometrial
 HEC-1-A 20.2 10.9 1.9 0.04
Ovarian
 SKOV-3x 11.0 6.5 1.7 0.05
 SKOV-3 10.0 6.2 1.6 0.07
Cervical
 C33-A 5.9 3.3 1.8 0.06
Pancreatic
 PaCa-2 8.2 5.4 1.5 0.01
Lung
 A549 9.7 10.8 0.9 0.76
 H460 4.7 4.5 1.0 0.28
 H520 5.2 6.2 0.9 0.29